- Find
- Manage
- Resources
When Will Generic Topamax Hit The Market?
A federal court has granted a preliminary injunction to drugmaker Johnson & Johnson that prohibits rival Mylan Laboratories Inc. from launching a generic formula of Topamax. Mylan won approval in September to begin selling a generic formula of the popular migraine and epilepsy treatment. The injunction will prevent the generic from immediately going to market.
Read moreMore information on "When Will Generic Topamax Hit The Market?"
From Our Experts
Migraine Prevention: Generic Topamax Approved
For all of you who are using Topamax for Migraine and headache prevention, there's good news. Generic topiramate has been approved by the... Read more »
Drugs Prescribed for Bipolar Disorder: Topamax (Topiramate)
Topamax is an anti-seizure drug that's sometimes prescribed as a mood stabilizer to treat bipolar disorder. Topamax - and the generic... Read more »
Migraine Preventive Depakote: Generics Approved by FDA
The FDA announced yesterday the approval of the first generic versions of Depakote delayed-release (divalproex sodium). Depakote is FDA... Read more »
The Economic Crisis May Hit Asthmatics Hard
How will asthma care and health be affected by the economy?It is clear that we are in the midst of difficult economic times. Some of us can... Read more »
Will Methadone Be Next on the FDA's Hit List?
After the FDA's recent decision to pull Darvon and Darvocet off the market even though it has been used successfully for pain relief by... Read more »
From Our Sources
Generic Topamax Approved and Available
The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures. The Topiramate ... Read more »
Court blocks generic Topamax
Mylan Labs has been banned from selling a generic version of Topamax until the patent expires in 2008. A U.S. district court ruled against the... Read more »
Generic Topamax gets tentative approval
Mylan Pharmaceuticals has received tentative approval from the Food and Drug Administration to sell generic Topamax. Ortho-McNeil's patent for... Read more »
Israeli firm to market generic version of Zocor
Israeli pharmaceutical company Teva says it has received tentative approval from the FDA to market a generic version of Zocor. Merck & Co.'s... Read more »
Generic Norvasc formulas spar on the U.S. market
A U.S. District Court has blocked all generic versions of Norvasc except for those made by Mylan until April 13, 2007. But now Pfizer--which makes... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
